^
Association details:
| Biomarker: | No biomarker |
|---|---|
| Cancer: | Ovarian Cancer |
| Drug: | carboplatin (Tubulin polymerization promoter) + pegylated liposomal doxorubicin (Topoisomerase II inhibitor) |
| Direction: | Sensitive |
Evidence:
Source:
Excerpt:
Low-grade serous (stage IC)/Grade I endometrioid (stage IC)....Other recommended regimens modified (Also for Stage II-IV disease on OV-C 6 of 11):...Carboplatin/liposomal doxorubicin ± maintenance letrozole (category 2B) or other hormonal therapy (category 2B)
